Lotus Pharmaceuticals, Inc. - FORM 10-Q - EX-32 - SECTION 1350 CERTIFICATION OF CFO - May 13, 2011

Attached files

file filename
10-Q - FORM 10-Q FOR 03-31-2011 - Lotus Pharmaceuticals, Inc.form_10-q.htm
EX-31 - RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CFO - Lotus Pharmaceuticals, Inc.ex_31-2.htm
EX-31 - RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CEO - Lotus Pharmaceuticals, Inc.ex_31-1.htm
EX-32 - SECTION 1350 CERTIFICATION OF CEO - Lotus Pharmaceuticals, Inc.ex_32-1.htm

Exhibit 32.2


Section 1350 Certification


In connection with the Quarterly Report of Lotus Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2011 as filed with the Securities and Exchange Commission (the “Report”), I, Yan Zeng, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



May 13, 2011

/s/ Yan Zeng

 

Yan Zeng, Chief Financial Officer, principal financial officer



A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the company and will be retained by the company and furnished to the Securities and Exchange Commission or its staff upon request.


Lotus Pharmaceuticals, Inc. Reports